The association between CFHR4 and several physiopathological characteristics in HCC suggests that it might be a possible predictive indicator for HCC, implying that CFHR4 may be a potential immune biomarker of HCC. This evidence concerns the gene CFHR4 and hepatocellular carcinoma.